Not applicableLooking for participantsNCT05633056What this trial is testingAn Adaptive Randomized Controlled TrialWho this might be right forMulti Drug Resistant TuberculosisHIV Infections Columbia University 360
Large-scale testing (Phase 3)Study completedNCT03086486What this trial is testingVarious Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant TuberculosisWho this might be right forTuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+4 more Global Alliance for TB Drug Development 181
Not applicableLooking for participantsNCT07206745What this trial is testingA Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacterial InfectionsWho this might be right forSevere Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection Henan University of Traditional Chinese Medicine 152
Large-scale testing (Phase 3)Study completedNCT02754765What this trial is testingEvaluating Newly Approved Drugs for Multidrug-resistant TBWho this might be right forTuberculosis, Multidrug-ResistantInfection, BacterialPulmonary Tuberculoses Médecins Sans Frontières, France 754
Not applicableStudy completedNCT02597621What this trial is testingBiomarkers for Therapy Response in Drug-resistant TuberculosisWho this might be right forTuberculosis, Multidrug-resistant Research Center Borstel 192
Not applicableLooking for participantsNCT05117788What this trial is testingBioneer Q-RFIA Clinical EvaluationWho this might be right forTuberculosis, Multidrug-Resistant Foundation for Innovative New Diagnostics, Switzerland 2,350
Testing effectiveness (Phase 2)Study completedNCT00727844What this trial is testingLinezolid to Treat Extensively-Drug Resistant TuberculosisWho this might be right forPulmonary TuberculosisMultidrug Resistant TuberculosisExtensively Drug Resistant Tuberculosis National Institute of Allergy and Infectious Diseases (NIAID) 41
Not applicableStudy completedNCT02727582What this trial is testingPharmacometric Optimization of Second Line Drugs for MDR Tuberculosis TreatmentWho this might be right forMultidrug-resistant Tuberculosis University of Cape Town 142
Testing effectiveness (Phase 2)Ended earlyNCT04575519What this trial is testingAdjunctive Acetylsalicylic Acid and Ibuprofen for TuberculosisWho this might be right forTuberculosis, PulmonaryTuberculosis, MDRTuberculosis Infection Fundació Institut Germans Trias i Pujol 426
Not applicableActive Not RecruitingNCT02129244What this trial is testingA Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection OutcomesWho this might be right forMDR-TBHIV Johns Hopkins University 3,600
Post-approval studies (Phase 4)Study completedNCT03867136What this trial is testingRefining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)Who this might be right forMultidrug Resistant Tuberculosis Huashan Hospital 354
Large-scale testing (Phase 3)Not Yet RecruitingNCT07675954What this trial is testingA 6-Month MDR-END Plus Regimen for Rifampicin-Resistant TuberculosisWho this might be right forRifampicin-Resistant Tuberculosis Seoul National University Hospital 294
Large-scale testing (Phase 3)Study completedNCT02589782What this trial is testingPragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)Who this might be right forTuberculosis, Multidrug-ResistantExtensively Drug-Resistant TuberculosisTuberculosis, Pulmonary Medecins Sans Frontieres, Netherlands 552
Not applicableUnknownNCT05267483What this trial is testingEvaluation of Usage Patterns and Outcomes in Patients Receiving Ceftolozane/Tazobactan (C/T) in Brazilian HospitalsWho this might be right forSepsis D'Or Institute for Research and Education 100
Not applicableEnded earlyNCT04783727What this trial is testingPredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant TuberculosisWho this might be right forTuberculosis, PulmonaryTuberculosis, Multidrug-ResistantBacterial Infections+1 more Research Center Borstel 4
Testing effectiveness (Phase 2)Study completedNCT02573350What this trial is testingA Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683Who this might be right forTuberculosis, Multidrug-Resistant Otsuka Pharmaceutical Development & Commercialization, Inc. 213
Testing effectiveness (Phase 2)Looking for participantsNCT05534750What this trial is testingEvaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)Who this might be right forTuberculosisMultidrug Resistant Tuberculosis Assistance Publique - Hôpitaux de Paris 60
Not applicableLooking for participantsNCT01212003What this trial is testingTraining Protocol on the Natural History of TuberculosisWho this might be right forMycobacterium InfectionsTuberculosis, Multidrug-ResistantLatent Tuberculosis+2 more National Institute of Allergy and Infectious Diseases (NIAID) 150
Large-scale testing (Phase 3)UnknownNCT03069534What this trial is testingStudy of Adjunctive Recombinant Human Interleukin-2 Therapy in Patients With MDR-TBWho this might be right forMDR TB The First Affiliated Hospital with Nanjing Medical University 500
Not applicableStudy completedNCT01201941What this trial is testingOperational Assessment of Laboratory Information System for MDR-TB in Lima, PeruWho this might be right forTuberculosis, Multidrug-Resistant Brigham and Women's Hospital 1,849